+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vical Inc - logo

Vical Incorporated is a biopharmaceutical company that develops products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), a therapeutic vaccine and prophylactic for herpes simplex virus type 2 and VL-2397 antifungal. The company was founded in 1987 and is headquartered in San Diego, California.

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019 - Product Thumbnail Image

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019

  • Report
  • 440 Pages
From
Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • 133 Pages
From
Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

  • Report
  • 380 Pages
From
Herpes Simplex Virus (HSV) Infections Therapeutics Pipeline Analysis, 2017 - Product Thumbnail Image

Herpes Simplex Virus (HSV) Infections Therapeutics Pipeline Analysis, 2017

  • Report
  • 77 Pages
From
Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2027 - Product Thumbnail Image

Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2027

  • Drug Pipelines
  • 169 Pages
From
Global DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Global DNA Vaccines Market 2019-2027

  • Report
  • 172 Pages
From
Global Herpes Treatment Market 2017-2021 - Product Thumbnail Image

Global Herpes Treatment Market 2017-2021

  • Report
  • 82 Pages
From
Middle East and Africa DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Middle East and Africa DNA Vaccines Market 2019-2027

  • Report
  • 72 Pages
From
Latin America DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Latin America DNA Vaccines Market 2019-2027

  • Report
  • 73 Pages
From
North America DNA Vaccines Market 2019-2027 - Product Thumbnail Image

North America DNA Vaccines Market 2019-2027

  • Report
  • 88 Pages
From
Europe DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Europe DNA Vaccines Market 2019-2027

  • Report
  • 83 Pages
From
Asia-Pacific DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Asia-Pacific DNA Vaccines Market 2019-2027

  • Report
  • 88 Pages
From
Global Subunit Vaccine Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global Subunit Vaccine Market Research and Forecast, 2018-2023

  • Report
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • 10 Pages
From
2019 Genital Herpes R&D Pipeline Drugs, Companies, Trials and Developments - Product Thumbnail Image

2019 Genital Herpes R&D Pipeline Drugs, Companies, Trials and Developments

  • Report
  • 67 Pages
From
Global DNA Vaccine Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global DNA Vaccine Market Research and Forecast, 2018-2023

  • Report
From
Hepatitis B - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H1 2018

  • Drug Pipelines
  • 365 Pages
From
Global DNA Vaccine Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 - Product Thumbnail Image

Global DNA Vaccine Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Report
  • 190 Pages
From
2019 Cytomegalovirus (HHV-5) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Cytomegalovirus (HHV-5) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 118 Pages
From
Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025

  • Report
  • 100 Pages
From
Loading Indicator
adroll